Long-term effects of experimental intracerebral hemorrhage: The role of iron

Journal of Neurosurgery

Volumn 104, Issue 2, 2006, Pages 305-312

  Hua, Ya ^b   Nakamura, Takehiro ^b   Keep, Richard F ^b   Wu, Jimin ^b   Schallert, Timothy ^b   Hoff, Julian T ^b   Xi, Guohua ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NONE

Author keywords

Brain atrophy; Deferoxamine; Ferritin; Intracerebral hemorrhage; Iron; Rat

Indexed keywords

DEFEROXAMINE; FERRITIN; IRON; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ATROPHY; BRAIN HEMORRHAGE; CAUDATE NUCLEUS; CONTROLLED STUDY; CONVALESCENCE; FERRITIN BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOREACTIVITY; IRON BLOOD LEVEL; IRON CHELATION; IRON TRANSPORT; MALE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; UPREGULATION;

ANIMALS; ATROPHY; BEHAVIOR, ANIMAL; BRAIN; DEFEROXAMINE; FERRITINS; INTRACRANIAL HEMORRHAGES; IRON; MALE; RATS; RATS, SPRAGUE-DAWLEY; SIDEROPHORES; UP-REGULATION;

EID: 33644518386     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2006.104.2.305     Document Type: Article

References (37)

1. Aruoma OI, Halliwell B, Dizdaroglu M: Iron ion-dependent modification of bases in DNA by the superoxide radical-generating system hypoxanthine/xanthine oxidase. J Biol Chem 264:13024-13028, 1989
2. Chan PH: Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21:2-14, 2001
3. Chan PH: Role of oxidants in ischemic brain damage. Stroke 27:1124-1129, 1996
4. Chen J, Jin K, Chen M, Pei W, Kawaguchi K, Greenberg DA, et al: Early detection of DNA strand breaks in the brain after transient focal ischemia: implications for the role of DNA damage in apoptosis and neuronal cell death. J Neurochem 69:232-245, 1997
5. Chiueh CC: Iron overload, oxidative stress, and axonal dystrophy in brain disorders. Pediatr Neurol 25:138-147, 2001
6. Connor JR, Menzies SL, Burdo JR, Boyer PJ: Iron and iron management proteins in neurobiology. Pediatr Neurol 25:118-129, 2001
7. Felberg RA, Grotta JC, Shirzadi AL, Strong R, Narayana P, Hill-Felberg SJ, et al: Cell death in experimental intracerebral hemorrhage: the "black hole" model of hemorrhagic damage. Ann Neurol 51:517-524, 2002
8. Fleischer JE, Lanier WL, Milde JH, Michenfelder JD: Failure of deferoxamine, an iron chelator, to improve neurologic outcome following complement ischemia in dogs. Stroke 18:124-127, 1987
9. Hall S, Rutledge JN, Schallert T: MRI, brain iron and experimental Parkinson's disease. J Neurol Sci 113:198-208, 1992
10. Halliwell B: Reactive oxygen species and the central nervous system. J Neurochem 59:1609-1623, 1992
11. Hua Y, Schallert T, Keep RF, Wu J, Hoff JT, Xi G: Behavioral tests after intracerebral hemorrhage in the rat. Stroke 33:2478-2484, 2002
12. Hua Y, Wu J, Kitaoka T, Keep RF, Schallert T, Hoff JT, et al: Iron overload, brain atrophy, calcification and long-term neurological deficits after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab 23 (Suppl 1):233, 2003 (Abstract)
13. Huang FP, Xi G, Keep RF, Hua Y, Nemoianu A, Hoff JT: Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg 96:287-293, 2002
14. Hurn PD, Koehler RC, Blizzard KK, Traystman RJ: Deferoxamine reduces early metabolic failure associated with severe cerebral ischemic acidosis in dogs. Stroke 26:688-695, 1995
15. Kase CS, Caplan LR: Intracerebral Hemorrhage. Boston: Butterworth-Heinemann, 1994
16. Keberle H: The biochemistry of desferrioxamine and its relation to iron metabolism. Ann NY Acad Sci 119:758-768, 1964
17. Koeppen AH, Dickson AC, McEvoy JA: The cellular reactions to experimental intracerebral hemorrhage. J Neurol Sci 134:102-112, 1995
18. Liachenko S, Tang P, Xu Y: Deferoxamine improves early postresuscitation reperfusion after prolonged cardiac arrest in rats. J Cereb Blood Flow Metab 23:574-581, 2003
19. Nagayama T, Lan J, Henshall DC, Chen D, O'Horo C, Simon RP, et al: Induction of oxidative DNA damage in the peri-infarct region after permanent focal cerebral ischemia. J Neurochem 75:1716-1728, 2000
20. Nakamura T, Keep RF, Hua Y, Schallert T, Hoff JT, Xi G: Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg 100:672-678, 2004
21. Palmer C, Roberts RL, Bero C: Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke 25:1039-1045, 1994
22. Peeling J, Del Bigio MR, Corbett D, Green AR, Jackson DM: Efficacy of disodium 4-[(tert-butylimino)methyl]benzene-1, 3-disulfonate N-oxide (NXY-059), a free radical trapping agent, in a rat model of hemorrhagic stroke. Neuropharmacology 40:433-439, 2001
23. Prass K, Ruscher K, Karsch M, Isaev N, Megow D, Priller J, et al: Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab 22:520-525, 2002
24. Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST: CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39:777-787, 2000
25. Schallert T, Upchurch M, Wilcox RE, Vaughn DM: Posture-independent sensorimotor analysis of inter-hemispheric receptor asymmetries in neostriatum. Pharmacol Biochem Behav 18:753-759, 1983
26. Siesjo BK, Agardh CD, Bengtsson F: Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1:165-211, 1989
27. Skriver EB, Olsen TS: Tissue damage at computed tomography following resolution of intracerebral hematomas. Acta Radiol Diagn (Stockh) 27:495-500, 1986
28. Strassmann G: Formation of hemosiderin and hematoidin after traumatic and spontaneous cerebral hemorrhages. Arch Pathol 47:205-210, 1949
29. Thompson KJ, Shoham S, Connor JR: Iron and neurodegenerative disorders. Brain Res Bull 55:155-164, 2001
30. Wagner KR, Dwyer BE: Hematoma removal, heme, and heme oxygenase following hemorrhagic stroke. Ann NY Acad Sci 1012:237-251, 2004
31. Wagner KR, Sharp FR, Ardizzone TD, Lu A, Clark JF: Heme and iron metabolism: role in cerebral hemorrhage. J Cereb Blood Flow Metab 23:629-652, 2003
32. Wang X, Mori T, Sumii T, Lo EH: Hemoglobin-induced cytotoxicity in rat cerebral cortical neurons: caspase activation and oxidative stress. Stroke 33:1882-1888, 2002
33. Wu J, Hua Y, Keep RF, Nakamura T, Hoff JT, Xi G: Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke 34:2964-2969, 2003
34. Wu J, Hua Y, Keep RF, Schallert T, Hoff JT, Xi G: Oxidative brain injury from extravasated erythrocytes after intracerebral hemorrhage. Brain Res 953:45-52, 2002
35. Xi G, Fewel ME, Hua Y, Thompson BG Jr, Hoff JT, Keep RF: Intracerebral hemorrhage: pathophysiology and therapy. Neurocritical Care 1:5-18, 2004
36. Xi G, Keep RF, Hoff JT: Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J Neurosurg 89:991-996, 1998
37. Xi G, Keep RF, Hua Y, Xiang J, Hoff JT: Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke 30:1247-1255, 1999